Thermedical Successfully Completes Feasibility Study for Treating Cardiac Arrhythmias Using Pulsed Field Ablation in Combination with SERF Ablation
Thermedical ®, a developer of advanced thermal-ablation systems to treat ventricular arrhythmias, announced today that it has completed a feasibility study utilizing Pulsed Field Ablation (PFA) therapy in combination with its SERF Ablation System and Durablate® Catheter for treating ventricular tachycardia (VT).
- Thermedical ®, a developer of advanced thermal-ablation systems to treat ventricular arrhythmias, announced today that it has completed a feasibility study utilizing Pulsed Field Ablation (PFA) therapy in combination with its SERF Ablation System and Durablate® Catheter for treating ventricular tachycardia (VT).
- PFA is an emerging technique that harnesses pulsed electrical field energy to deliver swift and precise tissue ablation in thin layers of the heart.
- “We are encouraged by the results from our pre-clinical feasibility study evaluating PFA technology integrated into our SERF Ablation System with the Durablate Catheter.
- The addition of PFA therapy to SERF ablation may offer a more complete approach to VT ablation and a practice-changing technology.